Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 449811-01-2
2. Ro 4402257
3. R1503
4. Ro4402257
5. Ro-4402257
6. Chembl1090089
7. Chebi:90685
8. R-1503
9. 8s2c9v11k4
10. Pamapimod (r-1503, Ro4402257)
11. 6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one
12. 6-(2,4-difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8h)-one
13. 6-(2,4-difluorophenoxy)-2-{[3-hydroxy-1-(2-hydroxyethyl)propyl]amino}-8-methylpyrido[2,3-d]pyrimidin-7(8h)-one
14. Pamapimod [usan]
15. Pamapimod [usan:inn]
16. Unii-8s2c9v11k4
17. 6-(2,4-difluorophenoxy)-2-((1,5-dihydroxypentan-3-yl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8h)-one
18. 6-(2,4-difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8h)-one
19. 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methylpyrido[2,3-d]pyrimidin-7(8h)-one
20. Pamapimodr-1503
21. Pamapimod [inn]
22. Pamapimod (inn/usan)
23. R 1503
24. Pamapimod [who-dd]
25. Gtpl9915
26. Schembl3636701
27. Dtxsid90963312
28. Bcp17491
29. Ex-a1084
30. Bdbm50314070
31. Mfcd25976551
32. S8125
33. Zinc30691792
34. Ccg-268715
35. Cs-5965
36. Compound 2b [pmid: 21375264]
37. Ac-33182
38. As-56094
39. Hy-10405
40. Ft-0673504
41. D08963
42. Q27162644
43. 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methyl-7h,8h-pyrido[2,3-d]pyrimidin-7-one
44. 6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)imino]-8-methyl-2,8-dihydropyrido[2,3-d]pyrimidin-7(3h)-one
45. Flw
46. Pyrido(2,3-d)pyrimidin-7(8h)-one, 6-(2,4-difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methyl-
| Molecular Weight | 406.4 g/mol |
|---|---|
| Molecular Formula | C19H20F2N4O4 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 8 |
| Exact Mass | 406.14526146 g/mol |
| Monoisotopic Mass | 406.14526146 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 591 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
67
PharmaCompass offers a list of Pamapimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pamapimod manufacturer or Pamapimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pamapimod manufacturer or Pamapimod supplier.
PharmaCompass also assists you with knowing the Pamapimod API Price utilized in the formulation of products. Pamapimod API Price is not always fixed or binding as the Pamapimod Price is obtained through a variety of data sources. The Pamapimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pamapimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pamapimod, including repackagers and relabelers. The FDA regulates Pamapimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pamapimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pamapimod supplier is an individual or a company that provides Pamapimod active pharmaceutical ingredient (API) or Pamapimod finished formulations upon request. The Pamapimod suppliers may include Pamapimod API manufacturers, exporters, distributors and traders.
Pamapimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pamapimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pamapimod GMP manufacturer or Pamapimod GMP API supplier for your needs.
A Pamapimod CoA (Certificate of Analysis) is a formal document that attests to Pamapimod's compliance with Pamapimod specifications and serves as a tool for batch-level quality control.
Pamapimod CoA mostly includes findings from lab analyses of a specific batch. For each Pamapimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pamapimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Pamapimod EP), Pamapimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pamapimod USP).
